How we secured a COVID‐19 convalescent plasma procurement scheme in Japan

• Published in: Transfusion (Philadelphia, Pa.) Vol. 61; no. 7; pp. 1998 - 2007
• Main Authors: Terada, Mari, Kutsuna, Satoshi, Togano, Tomiteru, Saito, Sho, Kinoshita, Noriko, Shimanishi, Yumiko, Suzuki, Tetsuya, Miyazato, Yusuke, Inada, Makoto, Nakamoto, Takahito, Nomoto, Hidetoshi, Ide, Satoshi, Sato, Mitsuhiro, Maeda, Kenji, Matsunaga, Akihiro, Satake, Masahiro, Matsubayashi, Keiji, Tsuno, Hirokazu, Kojima, Makiko, Kuramistu, Madoka, Tezuka, Kenta, Ikebe, Emi, Okuma, Kazu, Hamaguchi, Isao, Shiratori, Katsuyuki, Sato, Motohiko, Kawakami, Yuiko, Inaba, Kumi, Igarashi, Saori, Yamauchi, Reina, Matsumura, Mina, Ishimaru, Keiko, Zhang, Bijuan, Kuge, Chika, Ishihara, Maiko, Gouda, Miho, Tanaka, Keiko, Ishizaka, Yukihito, Ohmagari, Norio
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.07.2021; Wiley Subscription Services, Inc
• Subjects: Antibodies; antibody; Apheresis; Blood; Blood & organ donations; blood donation; Blood donors; convalescent plasma; COVID-19; How Do I; Infectious diseases; Pandemics; Plasmapheresis; Procurement; Public concern; Public health; SARS‐CoV‐2; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Spike protein; Viral diseases; Japan

Background In order to tackle the COVID‐19 pandemic, a COVID‐19 convalescent plasma (CCP) procurement program was initiated in Japan in April 2020. The program was a collaboration between a government‐managed national hospital, an infectious disease research institute, and a blood banking organizati...